Centrexion Therapeutics is a late clinical-stage biopharmaceutical company focused on becoming a leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.
At Centrexion Therapeutics, we have a broad pipeline that reflects our mission to tackle the problem of chronic pain directly. We are focused on developing treatments that address new or emerging pharmacological targets and deliver them in ways that best alleviate particular types of chronic pain. Our drug candidates include: topical gel, joint or deeper tissue injection, spinal delivery and three separate oral therapies. We believe that our broad pipeline of non-opioid and non-addictive drug candidates is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions.